IRIS
RUPERTO, NICOLINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.933
AS - Asia 961
NA - Nord America 820
Continente sconosciuto - Info sul continente non disponibili 205
SA - Sud America 71
AF - Africa 22
OC - Oceania 3
Totale 8.015
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.783
US - Stati Uniti d'America 763
SG - Singapore 351
CN - Cina 213
VN - Vietnam 148
BD - Bangladesh 136
FR - Francia 56
BR - Brasile 47
HK - Hong Kong 38
FI - Finlandia 31
CA - Canada 24
DE - Germania 13
JP - Giappone 12
AR - Argentina 10
GB - Regno Unito 10
IN - India 9
CR - Costa Rica 8
ID - Indonesia 8
IQ - Iraq 7
RU - Federazione Russa 6
SE - Svezia 6
CH - Svizzera 5
DZ - Algeria 5
KE - Kenya 5
MX - Messico 5
TR - Turchia 5
TW - Taiwan 5
EC - Ecuador 4
HN - Honduras 4
JM - Giamaica 4
NL - Olanda 4
PK - Pakistan 4
TH - Thailandia 4
BY - Bielorussia 3
CO - Colombia 3
EG - Egitto 3
IL - Israele 3
VE - Venezuela 3
AT - Austria 2
CL - Cile 2
IE - Irlanda 2
JO - Giordania 2
LB - Libano 2
MA - Marocco 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PL - Polonia 2
SV - El Salvador 2
TN - Tunisia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BS - Bahamas 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
ES - Italia 1
GM - Gambi 1
GR - Grecia 1
GT - Guatemala 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TG - Togo 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
Totale 7.810
Salva come PNG Salva come JPEG
Città #
Genova 2.907
Genoa 1.775
Rapallo 521
Vado Ligure 468
San Jose 178
Singapore 174
Ashburn 144
Beijing 48
Lauterbourg 46
Ho Chi Minh City 41
New York 40
Hanoi 37
Hong Kong 37
Helsinki 31
Santa Clara 21
Council Bluffs 17
Buffalo 15
Chicago 14
Haiphong 13
Los Angeles 13
Bordighera 12
Frankfurt am Main 10
Tokyo 10
Orem 9
Naples 8
Montreal 7
Bologna 6
Dallas 6
London 6
Alessandria 5
Charlotte 5
Da Nang 5
Princeton 5
San José 5
São Paulo 5
Zurich 5
Amsterdam 4
Boardman 4
Hillsboro 4
Las Vegas 4
Milan 4
Montoro 4
Nairobi 4
Portland 4
Queens 4
Rome 4
Toronto 4
Washington 4
Baghdad 3
Bangkok 3
Can Tho 3
City of London 3
East Brunswick 3
Hempstead 3
Istanbul 3
Lake Worth 3
Lithonia 3
Lynnwood 3
Miami 3
Paris 3
Phoenix 3
Phủ Lý 3
Quito 3
Rio de Janeiro 3
San Francisco 3
Shanghai 3
Sona 3
Staten Island 3
Tianjin 3
Abingdon 2
Alajuela 2
Amman 2
Biên Hòa 2
Blumenau 2
Bogotá 2
Buenos Aires 2
Bắc Ninh 2
Carapicuíba 2
Cardiff 2
Chennai 2
Cleveland 2
Columbus 2
Delhi 2
Des Moines 2
Glendale 2
Gothenburg 2
Green Bay 2
Guangzhou 2
Hải Dương 2
Jakarta 2
Kansas City 2
L’Aquila 2
Manlius 2
Maracaibo 2
Minsk 2
Montego Bay 2
Montgomery 2
New Delhi 2
New Taipei City 2
Nuremberg 2
Totale 6.822
Salva come PNG Salva come JPEG
Nome #
A Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic Arthritis 216
Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score 206
Development and validation of a composite disease activity score for juvenile idiopathic arthritis 205
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome 205
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis 201
2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European league against Rheumatism/American college of Rheumatology/Paediatric rheumatology international trials organisation collaborative initiative 201
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in juvenile dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation collaborative initiative 196
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects 192
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative 188
Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 185
Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study 185
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 182
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative 172
Development and testing of a hybrid measure of muscle strength in juvenile dermatomyositis for use in routine care 172
Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy 168
Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. 167
A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry 164
Performance of different diagnostic criteria for familial Mediterranean fever in children with periodic fevers: Results from a multicenter international registry 161
Clinical trials in children and adolescents with systemic lupus erythematosus: Methodological aspects, regulatory landscape and future opportunities 157
Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study. 151
Tapering Canakinumab Monotherapy in Patients with Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results from an Open‐label, Randomized Phase IIIb/IV Study 150
The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry 146
The Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 145
An international delphi survey for the definition of the variables for the development of new classification criteria for periodic fever aphtous stomatitis pharingitis cervical adenitis (PFAPA) 145
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative 137
American College of Rheumatology Provisional Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus 137
Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study 137
Current and future perspectives in the management of juvenile idiopathic arthritis 133
Current medical treatments for juvenile idiopathic arthritis 127
Treatment of juvenile idiopathic arthritis: what's new? 124
Recommendations for collaborative paediatric research including biobanking in Europe: a Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative 123
The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry 121
Development and testing of reduced versions of the MMT-8 in juvenile dermatomyositis 121
The PRINTO juvenile dermatomyositis trial - Authors' reply 119
Treating juvenile idiopathic arthritis to target: Recommendations of an international task force 116
Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: Results from the 5-year long-term extension of the phase III pivotal trials 114
Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study 114
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: Results of a multicentre, double-blind, randomised-withdrawal trial 113
A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis 113
Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus 112
Measuring Disease Damage and Its Severity in Childhood-Onset Systemic Lupus Erythematosus 101
Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis 101
Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial 100
Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: Post hoc radiographic analysis from two randomized controlled trials 99
Two-year efficacy and safety of etanercept in pediatric patients with extended oligoarthritis, enthesitisrelated arthritis, or psoriatic arthritis 98
Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: Results of a phase 1, open-label, multicenter study 98
Development and initial validation of parent and child versions of the Juvenile Arthritis Disease Activity Score 95
International consensus for a definition of disease flare in lupus 94
Validation of the PEDiatric Behçet’s Disease classification criteria: an evidence-based approach 83
Is it worth including subtalar joint in ultrasound ankle assessment of patients with juvenile idiopathic arthritis? 81
Extrapolation or controlled trials in paediatrics: The current dilemma 78
Disease activity, overweight, physical activity and screen time in a cohort of patients with juvenile idiopathic arthritis 78
Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the "comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS" (STARS) trial 76
Defining criteria for disease activity states in juvenile dermatomyositis based on the Juvenile Dermatomyositis Activity Index 70
Validity and Reliability of Four Parent/Patient-Reported Outcome Measures for Juvenile Idiopathic Arthritis Remote Monitoring 69
Preface 60
Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task force 57
Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers 57
Outcome Scores in Pediatric Rheumatology 56
Towards the definition of disease phenotypes in paediatric SAPHO syndrome: a national multicentric study 47
null 47
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study 43
Paediatric rheumatologists do not score the physician's global assessment of juvenile idiopathic arthritis disease activity in the same way 41
Factors for Consideration by Pediatric Rheumatologists When Scoring the Physician Global Assessment of Disease Activity in Juvenile Idiopathic Arthritis: First Step Toward an Internal Consensus 27
Daily Living Activity Dataset of Juvenile Rheumatic Patients From Wearables Data 20
Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial 18
Totale 8.015
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.231
article - articoli 28.231
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.462
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022650 65 30 30 54 14 62 17 133 61 68 28 88
2022/2023631 59 76 8 44 114 78 16 41 99 8 80 8
2023/2024428 33 47 13 54 43 65 19 30 18 17 22 67
2024/20251.209 38 75 57 64 127 152 104 235 36 72 119 130
2025/20262.437 270 64 96 108 320 178 349 108 208 262 235 239
2026/2027227 227 0 0 0 0 0 0 0 0 0 0 0
Totale 8.015